A detailed history of King Luther Capital Management Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, King Luther Capital Management Corp holds 4,626 shares of EW stock, worth $305,269. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,626
Previous 4,974 7.0%
Holding current value
$305,269
Previous $475,000 10.11%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$84.3 - $94.31 $29,336 - $32,819
-348 Reduced 7.0%
4,626 $427,000
Q1 2024

May 13, 2024

SELL
$72.54 - $95.56 $34,093 - $44,913
-470 Reduced 8.63%
4,974 $475,000
Q4 2023

Feb 09, 2024

SELL
$61.71 - $77.76 $14,933 - $18,817
-242 Reduced 4.26%
5,444 $415,000
Q3 2023

Nov 13, 2023

SELL
$69.28 - $93.38 $148,259 - $199,833
-2,140 Reduced 27.34%
5,686 $393,000
Q2 2023

Aug 10, 2023

SELL
$81.41 - $94.33 $132,779 - $153,852
-1,631 Reduced 17.25%
7,826 $738,000
Q1 2023

May 11, 2023

SELL
$74.26 - $84.51 $64,903 - $73,861
-874 Reduced 8.46%
9,457 $782,000
Q3 2022

Nov 10, 2022

SELL
$82.37 - $107.29 $80,393 - $104,715
-976 Reduced 8.63%
10,331 $854,000
Q2 2022

Aug 11, 2022

BUY
$86.5 - $128.27 $41,520 - $61,569
480 Added 4.43%
11,307 $1.08 Million
Q1 2022

May 11, 2022

BUY
$101.96 - $128.34 $7,545 - $9,497
74 Added 0.69%
10,827 $1.28 Million
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $31,379 - $38,550
-295 Reduced 2.67%
10,753 $1.39 Million
Q3 2021

Nov 10, 2021

SELL
$102.91 - $122.75 $54,336 - $64,812
-528 Reduced 4.56%
11,048 $1.25 Million
Q2 2021

Aug 13, 2021

SELL
$83.84 - $104.76 $4,359 - $5,447
-52 Reduced 0.45%
11,576 $1.2 Million
Q1 2021

May 12, 2021

SELL
$78.68 - $90.67 $46,185 - $53,223
-587 Reduced 4.81%
11,628 $973,000
Q4 2020

Feb 10, 2021

SELL
$71.69 - $91.23 $28,389 - $36,127
-396 Reduced 3.14%
12,215 $1.11 Million
Q3 2020

Nov 12, 2020

BUY
$67.19 - $87.44 $424,237 - $552,096
6,314 Added 100.27%
12,611 $1.01 Million
Q2 2020

Aug 12, 2020

BUY
$57.54 - $76.95 $252,543 - $337,733
4,389 Added 230.03%
6,297 $435,000
Q1 2020

May 13, 2020

SELL
$52.41 - $81.0 $83,593 - $129,195
-1,595 Reduced 45.53%
1,908 $360,000
Q4 2019

Feb 12, 2020

BUY
$71.7 - $82.09 $100,738 - $115,336
1,405 Added 66.97%
3,503 $817,000
Q3 2019

Nov 12, 2019

BUY
$61.55 - $75.43 $129,131 - $158,252
2,098 New
2,098 $461,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track King Luther Capital Management Corp Portfolio

Follow King Luther Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.